Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06486857

Accuracy Assessment of a Novel Gas Detection Approach in Dyslipidemia Diagnosis

This study aims to validate the feasibility and accuracy of a novel gas detection method for dyslipidemia screening by analyzing the lipid profile of human breath metabolites. It explores a simple, rapid, and non-invasive method for screening dyslipidemia. The application prospects of this method are broad; it can be used not only for early screening and monitoring of dyslipidemia in hospitals and communities, providing strong support for the prevention of cardiovascular diseases, but also for the routine monitoring and treatment effectiveness evaluation of patients with hyperlipidemia, offering a scientific basis for personalized treatment plans. This study not only has profound scientific value but also provides a theoretical basis for the development of subsequent new clinical testing methods.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Beijing Anzhen hospital

Beijing, Beijing Municipality, 100029, China

Location contact

Yan Yan, Dr.

PRINCIPAL_INVESTIGATOR

Zeqi Dai, PhD

CONTACT

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years
  • Voluntarily signed the informed consent form

Exclusion criteria

  • Patients with lung cancer, asthma, chronic obstructive pulmonary disease, pulmonary cystic fibrosis, or acute respiratory distress syndrome
  • Women who are pregnant or breastfeeding
  • Patients with chronic kidney disease (GFR < 60 ml/min) or cirrhosis
  • Individuals unable to cooperate with the collection of exhaled gas samples

Treatment and study plan

a novel gas detection method for dyslipidemia screening

Diagnostic Test

Multidimensional Mass Spectrometry Technologies Based on Exhaled Metabolic Fingerprint Spectra for Dyslipidemia Detection

Primary outcomes

  1. accuracy of cholesterol testing

    Time frame: within 1 week day of sample collection

Sponsors and collaborators

Lead sponsor

Beijing Anzhen Hospital

Other

Registry information

Official study title

Accuracy Validation Study of a Novel Gas Detection Method for Dyslipidemia

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Jul 5, 2024
Registry last updated
Jul 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.